Which office must practitioners register with to administer controlled substances for a Narcotic Treatment Program?

Which office must practitioners register with to administer controlled substances for a Narcotic Treatment Program?

• A. DEA
• B. FDA
• C. CSAT
• D. HHS

Answer: (C)

Practitioners must register with the Center for Substance Abuse Treatment (CSAT) to administer controlled substances for a Narcotic Treatment Program (NTP). CSAT is a division of the Substance Abuse and Mental Health Services Administration (SAMHSA) and plays a crucial role in overseeing and regulating treatment programs for substance use disorders, particularly concerning opioid addiction. NTPs are specifically designed to provide medication-assisted treatment (MAT) for individuals addicted to narcotics, and CSAT establishes the guidelines and requirements that practitioners must follow to ensure compliance and safety. By registering with CSAT, practitioners are able to obtain the necessary credentials to participate in programs that use controlled substances to treat opioid addiction. Other options involve different regulatory bodies: the DEA (Drug Enforcement Administration) is primarily concerned with the enforcement of the Controlled Substances Act and the regulation of controlled substances but does not specifically manage NTP registrations. The FDA (Food and Drug Administration) oversees the approval and regulation of pharmaceuticals and medical devices and does not directly handle treatment program certifications. HHS (Department of Health and Human Services) encompasses a broader range of health-related issues but does not specifically register practitioners for NTPs. Therefore, registering with CSAT is the correct requirement for practitioners looking to administer controlled substances

Practitioners must register with the Center for Substance Abuse Treatment (CSAT) to administer controlled substances for a Narcotic Treatment Program (NTP). CSAT is a division of the Substance Abuse and Mental Health Services Administration (SAMHSA) and plays a crucial role in overseeing and regulating treatment programs for substance use disorders, particularly concerning opioid addiction.

NTPs are specifically designed to provide medication-assisted treatment (MAT) for individuals addicted to narcotics, and CSAT establishes the guidelines and requirements that practitioners must follow to ensure compliance and safety. By registering with CSAT, practitioners are able to obtain the necessary credentials to participate in programs that use controlled substances to treat opioid addiction.

Other options involve different regulatory bodies: the DEA (Drug Enforcement Administration) is primarily concerned with the enforcement of the Controlled Substances Act and the regulation of controlled substances but does not specifically manage NTP registrations. The FDA (Food and Drug Administration) oversees the approval and regulation of pharmaceuticals and medical devices and does not directly handle treatment program certifications. HHS (Department of Health and Human Services) encompasses a broader range of health-related issues but does not specifically register practitioners for NTPs. Therefore, registering with CSAT is the correct requirement for practitioners looking to administer controlled substances